|
1
|
Clarke R, Du H, Kurmi O, Parish S, Yang M,
Arnold M, Guo Y, Bian Z, Wang L, Chen Y, et al: Burden of carotid
artery atherosclerosis in Chinese adults: Implications for future
risk of cardiovascular diseases. Eur J Prev Cardiol. 24:647–656.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barquera S, Pedroza-Tobías A, Medina C,
Hernández-Barrera L, Bibbins-Domingo K, Lozano R and Moran AE:
Global overview of the epidemiology of atherosclerotic
cardiovascular disease. Arch Med Res. 46:328–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PLoS Med.
3:e4422006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen M, Masaki T and Sawamura T: LOX-1,
the receptor for oxidized low-density lipoprotein identified from
endothelial cells: Implications in endothelial dysfunction and
atherosclerosis. Pharmacol Ther. 95:89–100. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hong D, Bai YP, Gao HC, Wang X, Li LF,
Zhang GG and Hu CP: Ox-LDL induces endothelial cell apoptosis via
the LOX-1-dependent endoplasmic reticulum stress pathway.
Atherosclerosis. 235:310–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bao MH, Zhang YW and Zhou HH: Paeonol
suppresses oxidized low-density lipoprotein induced endothelial
cell apoptosis via activation of LOX-1/p38MAPK/NF-κB pathway. J
Ethnopharmacol. 146:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu F, Sun Y, Chen Y, Sun Y, Li R, Liu C,
Zhang C, Wang R and Zhang Y: Endothelial cell apoptosis is
responsible for the formation of coronary thrombotic
atherosclerotic plaques. Tohoku J Exp Med. 218:25–33. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Durand E, Scoazec A, Lafont A, Boddaert J,
Al Hajzen A, Addad F, Mirshahi M, Desnos M, Tedgui A and Mallat Z:
In vivo induction of endothelial apoptosis leads to vessel
thrombosis and endothelial denudation a clue to the understanding
of the mechanisms of thrombotic plaque erosion. Circulation.
109:2503–2506. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Badimon L and Vilahur G: Thrombosis
formation on atherosclerotic lesions and plaque rupture. J Intern
Med. 276:618–632. 2015. View Article : Google Scholar
|
|
10
|
Raskob GE, Angchaisuksiri P, Blanco AN,
Büller H, Gallus A, Hunt BJ, Hylek EM, Kakkar TL, Konstantinides
SV, Mccumber M, et al: Thrombosis: A major contributor to global
disease burden. Semin Thromb Hemost. 40:724–735. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Mu Q, Zhou Z, Song H, Zhang Y, Wu
F, Jiang M, Wang F, Zhang W, Li L, et al: Protective effect of
irisin on atherosclerosis via suppressing oxidized low density
lipoprotein induced vascular inflammation and endothelial
dysfunction. PLoS One. 11:e01580382016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang L, Hao Q, Wang YD, Wang WJ and Li DJ:
Protective effects of dehydroepiandrosterone on atherosclerosis in
ovariectomized rabbits via alleviating inflammatory injury in
endothelial cells. Atherosclerosis. 214:47–57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang GF, Shi CG, Sun MZ, Wang L, Wu SX,
Wang HF, Xu ZQ and Chen DM: Tetramethylpyrazine attenuates
atherosclerosis development and protects endothelial cells from
ox-LDL. Cardiovasc Drugs Ther. 27:199–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee CW, Hwang I, Park CS, Lee H, Park DW,
Kang SJ, Lee SW, Kim YH Park SW and Park SJ: Comparison of
differential expression of P2Y12 receptor in culprit
coronary plaques in patients with acute myocardial infarction
versus stable angina pectoris. Am J Cardiol. 108:799–803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jeong HS, Hong SJ, Cho SA, Kim JH, Cho JY,
Lee SH, Joo HJ, Park JH, Yu CW and Lim DS: Comparison of ticagrelor
versus prasugrel for inflammation, vascular function, and
circulating endothelial progenitor cells in diabetic patients with
non-ST-segment elevation acute coronary syndrome requiring coronary
stenting. JACC Cardiovasc Interv. 10:1646–1658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Warnholtz A, Ostad MA, Velich N, Trautmann
C, Schinzel R, Walter U and Munzel T: A single loading dose of
clopidogrel causes dose-dependent improvement of endothelial
dysfunction in patients with stable coronary artery disease:
Results of a double-blind, randomized study. Atherosclerosis.
196:689–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Willoughby SR, Luu LJ, Cameron JD, Nelson
AJ, Schultz CD, Worthley SG and Worthley MI: Clopidogrel improves
microvascular endothelial function in subjects with stable coronary
artery disease. Heart Lung Circ. 23:534–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim HK, Jeong MH, Lim KS, Kim JH, Lim HC,
Kim MC, Hong YJ, Kim SS, Park KH and Chang KS: Effects of
ticagrelor on neointimal hyperplasia and endothelial function,
compared with clopidogrel and prasugrel, in a porcine coronary
stent restenosis model. Int J Cardiol. 240:326–331. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Preusch MR, Rusnak J, Staudacher K, Mogler
C, Uhlmann L, Sievers P, Bea F, Katus HA, Blessing E and Staudacher
I: Ticagrelor promotes atherosclerotic plaque stability in a mouse
model of advanced atherosclerosis. Drug Des Devel Ther.
10:2691–2699. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren H, Li ML, Jiang J, Zhang Y, Zhang Y
and Zhu X: Effects of clopidogrel on vascular proliferation and
apoptosis in an atherosclerotic rabbit model. J Cardiovasc
Pharmacol. 55:617–624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Liang X, Wang Y, Xu Z and Li G:
Investigation of highly expressed PCSK9 in atherosclerotic plaques
and ox-LDL-induced endothelial cell apoptosis. Mol Med Rep.
16:1817–1825. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Capodanno D, Dharmashankar K and
Angiolillo DJ: Mechanism of action and clinical development of
ticagrelor, a novel platelet ADP P2Yreceptor antagonist. Expert Rev
Cardiovasc Ther. 8:151–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Chen L, Li H, Yang J, Gong Z, Wang
B and Zhao X: Clopidogrel reduces apoptosis and promotes
proliferation of human vascular endothelial cells induced by
palmitic acid via suppression of the long non-coding RNA HIF1A-AS1
in vitro. Mol Cell Biochem. 404:203–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sachais BS: Platelet-endothelial
interactions in atherosclerosis. Curr Atheroscler Rep. 3:412–416.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nylander S, Femia EA, Scavone M, Berntsson
P, Asztély AK, Nelander K, Löfgren L, Nilsson RG and Cattaneo M:
Ticagrelor inhibits human platelet aggregation via adenosine in
addition to P2Y12 antagonism. J Thromb Haemost. 11:1867–1876.
2013.PubMed/NCBI
|
|
27
|
Heitzer T, Rudolph V, Schwedhelm E,
Karstens M, Sydow K, Ortak M, Tschentscher P, Meinertz T, Böger R
and Baldus S: Clopidogrel improves systemic endothelial nitric
oxide bioavailability in patients with coronary artery disease:
Evidence for antioxidant and antiinflammatory effects. Arterioscler
Thromb Vasc Biol. 26:1648–1652. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gwozdz P, Csanyi G, Luzak B, Gajda M,
Mateuszuk L, Chmura-Skirlinska A, Watala C and Chlopicki S:
Endothelial dysfunction and circulating platelet activation in
apoE/LDLR/-mice along the development of atherosclerosis. In:
Conference on Frontiers in Cardiovascular Biology. Cardiovasc Res.
87 Suppl:S94. 2010.
|
|
29
|
Wang W, Luo J, Xiang F, Liu X, Jiang M,
Liao L and Hu J: Nucleolin down-regulation is involved in
ADP-induced cell cycle arrest in S phase and cell apoptosis in
vascular endothelial cells. PLoS One. 9:e1101012014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coutinho-Silva R, Stahl L, Cheung KK, de
Campos NE, de Oliveira Souza C, Ojcius DM and Burnstock G: P2X and
P2Y purinergic receptors on human intestinal epithelial carcinoma
cells: Effects of extracellular nucleotides on apoptosis and cell
proliferation. Am J Physiol Gastrointest Liver Physiol.
288:G1024–G1035. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seidah NG, Benjannet S, Wickham L,
Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A and Chrétien
M: The secretory proprotein convertase neural apoptosis-regulated
convertase 1 (NARC-1): Liver regeneration and neuronal
differentiation. Proc Natl Acad Sci USA. 100:928–933. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kysenius K, Muggalla P, Mätlik K, Arumäe U
and Huttunen HJ: PCSK9 regulates neuronal apoptosis by adjusting
ApoER2 levels and signaling. Cell Mol Life Sci. 69:1903–1906. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS
and Liu LS: PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL
via Bcl/Bax-caspase9-caspase3 pathway. Mol Cell Biochem.
359:347–358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gurbel PA, Navarese EP and Tantry US:
Exploration of PCSK9 as a cardiovascular risk factor: Is there a
link to the platelet? J Am Coll Cardiol. 70:1463–1466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li S, Zhu CG, Guo YL, Xu RX, Zhang Y, Sun
J and Li JJ: The relationship between the plasma PCSK9 levels and
platelet indices in patients with stable coronary artery disease. J
Atheroscler Thromb. 22:76–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Navarese EP, Kolodziejczak M, Winter MP,
Alimohammadi A, Lang IM, Buffon A, Lip GY and Siller-Matula JM:
Association of PCSK9 with platelet reactivity in patients with
acute coronary syndrome treated with prasugrel or ticagrelor: The
PCSK9-REACT study. Int J Cardiol. 227:644–649. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen TG, Chen TL, Chang HC, Tai YT, Cherng
YG, Chang YT and Chen RM: Oxidized low-density lipoprotein induces
apoptotic insults to mouse cerebral endothelial cells via a
Bax-mitochondria-caspase protease pathway. Toxicol Appl Pharmacol.
219:42–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu W, Ying H, Tong F, Zhang C, Quan Y and
Zhang Y: Protective effect of the silkworm protein 30Kc6 on human
vascular endothelial cells damaged by oxidized low density
lipoprotein (Ox-LDL). PLoS One. 8:e687462013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Jia YH, Zhao XS, Zhou FH, Pan YY,
Wan Q, Cui XB, Sun XG, Chen YY, Zhang Y and Cheng SB:
Trichosanatine alleviates oxidized low-density lipoprotein induced
endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway.
Am J Transl Res. 8:5455–5464. 2016.PubMed/NCBI
|
